View Cart (0 items)
Pharmaceutical

Asia’s biggest drugmaker plunges in Tokyo trading

May 14, 2012
/ Print / Reprints /
| Share More
/ Text Size+

TOKYO — Takeda Pharmaceutical Co., Asia’s biggest drugmaker, fell 4.3% in Tokyo trading after forecasting a 40% drop in operating profit, Bloomberg reported.

The fall was the most in 14 months.

The company said the drop in operating profit was due to acquisition costs and higher research expenses.

You must login or register in order to post a comment.

Related Events